XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating activities:    
Net income $ 122,021 $ 50,537
Income from discontinued operations (4,600) (865)
Income from continuing operations 117,421 49,672
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 20,918 13,505
Amortization and impairments to operating lease assets 14,092 17,340
Depreciation 19,993 19,381
Amortization of acquired intangible assets 5,610 20,010
Amortization of debt discount and issuance costs 2,226 2,310
Provision for bad debts 28,719 23,024
Deferred income taxes 23,516 (343)
Loss on disposals of property and equipment 114 38
Gain on investments (442) (575)
Unrealized loss on assets held for sale   647
Changes in assets and liabilities:    
Accounts and financing receivables (46,493) (52,716)
Prepaid expenses and other current assets 6,829 (2,143)
Cloud computing implementation assets (14,071) (11,314)
Accounts payable (34,588) 9,755
Accrued payroll and benefits (20,311) (6,073)
Accrued liabilities (29,066) 25,130
Deferred revenue (12,028) (13,540)
Operating lease liabilities (10,594) (20,441)
Other assets and liabilities (5,888) (1,314)
Net cash provided by operating activities-continuing operations 65,957 72,353
Net cash provided by operating activities-discontinued operations 4,340 9,515
Net cash provided by operating activities 70,297 81,868
Investing activities:    
Capital expenditures (21,094) (19,612)
Proceeds from sales of marketable securities 2,426 626
Purchases of marketable securities (1,548) (498)
Net cash used in investing activities (20,216) (19,484)
Financing activities:    
Proceeds from exercise of stock options 9,833 15,313
Employee taxes paid on withholding shares (12,198) (6,505)
Proceeds from stock issued under Colleague Stock Purchase Plan 567 359
Repurchases of common stock for treasury (74,066) (160,549)
Proceeds from issuance of long-term debt 9,873  
Repayments of long-term debt (9,873)  
Net cash used in financing activities (75,864) (151,382)
Net decrease in cash, cash equivalents and restricted cash (25,783) (88,998)
Cash, cash equivalents and restricted cash at beginning of period 221,202 275,075
Cash, cash equivalents and restricted cash at end of period 195,419 186,077
Non-cash investing and financing activities:    
Accrued capital expenditures 5,085 4,053
Accrued liability for repurchases of common stock 400 2,400
Accrued excise tax on share repurchases $ 301 $ 2,358